ALKERMES | ALKS - Eps Gewinn Pro Aktie

Aktienkurs
37.55
Täglich Wechseln
-0.81 -2.11%
Monatlich
11.21%
Jährlich
19.51%
Q2 Prognose
33.96

Fiscal Kalender Aktuell Konsens Zuletzt Datum
FY2026Q1 Mar/2026 -0.40 -0.4 0.13 May/05
FY2025Q4 Dec/2025 0.29 0.42 1.05 Feb/25
FY2025Q3 Sep/2025 0.49 0.4 0.73 Oct/28
FY2025Q2 Jun/2025 0.52 0.39 0.72 Jul/29
FY2025Q1 Mar/2025 0.13 0.39 0.43 May/01




Eps Veränderung Datum
AbbVie USD 2.65 0.06 2026-03
Acadia Pharmaceuticals USD 0.02 1.58 2026-03
ALKERMES USD -0.4 0.69 2026-03
Amgen USD 5.15 0.14 2026-03
Biogen USD 3.57 1.58 2026-03
BioMarin Pharmaceutical USD 0.76 0.3 2026-03
Bristol-Myers Squibb USD 1.58 0.32 2026-03
Coherus Biosciences USD -0.43 0.06 2025-12
Eli Lilly USD 8.55 1.01 2026-03
Gilead Sciences USD 2.03 0.17 2026-03
Heron Therapeutics USD -0.02 0.02 2025-12
Ionis Pharmaceuticals USD -0.56 0.85 2026-03
J&J USD 2.7 0.24 2026-03
Malin Corporation EUR -0.06 0.1 2023-12
Merck USD -1.28 3.32 2026-03
Minerva Neurosciences USD -0.56 3.53 2024-12
Nektar Therapeutics USD -1.35 1.17 2025-12
Neurocrine Biosciences USD 1.94 0.06 2026-03
Otsuka Holdings JPY 186.31 62.06 2026-03
Ovoca Bio EUR -0.06 0.01 2025-06
Pfizer USD 0.75 0.09 2026-03
Regeneron Pharmaceuticals USD 9.47 1.97 2026-03
Vertex Pharmaceuticals USD 4.47 0.56 2026-03